Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck (Q44740191)

From Wikidata
Jump to navigation Jump to search
scientific article published in January 1997
edit
Language Label Description Also known as
English
Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck
scientific article published in January 1997

    Statements

    Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck (English)
    1 January 1997
    235-245

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit